Advertisement
U.S. markets closed
  • S&P 500

    4,550.58
    -4.31 (-0.09%)
     
  • Dow 30

    35,430.42
    +13.44 (+0.04%)
     
  • Nasdaq

    14,258.49
    -23.27 (-0.16%)
     
  • Russell 2000

    1,803.81
    +11.00 (+0.61%)
     
  • Crude Oil

    77.72
    +1.31 (+1.71%)
     
  • Gold

    2,045.40
    +5.40 (+0.26%)
     
  • Silver

    25.42
    +0.12 (+0.47%)
     
  • EUR/USD

    1.0972
    -0.0027 (-0.24%)
     
  • 10-Yr Bond

    4.2710
    -0.0650 (-1.50%)
     
  • GBP/USD

    1.2693
    -0.0006 (-0.05%)
     
  • USD/JPY

    147.0970
    -0.3290 (-0.22%)
     
  • Bitcoin USD

    37,839.79
    -140.13 (-0.37%)
     
  • CMC Crypto 200

    778.64
    -6.86 (-0.87%)
     
  • FTSE 100

    7,423.46
    -31.78 (-0.43%)
     
  • Nikkei 225

    33,321.22
    -87.17 (-0.26%)
     

SOL Global's HeavenlyRx To Acquire Airganics

HeavenlyRx, a portfolio company of SOL Global Investments Corp (OTC: SOLCF), has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.

The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.

Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.

All brands are focused to capture the CBD wellness space and already have distribution channels.

Related Links:

Discussing Sol Global's M Hemp Biomass Investment With CEO Brady Cobb

OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement